FREQUENCY OF STAPHYLOCOCCUS AUREUS IN BLOOD STREAM INFECTIONS AND THEIR DRUG SUSCEPTIBILITY PATTERN

Nadia Aslam; Nazma Kiran; Naima Mehdi; Mateen Izhar; Tanveer Zia; Hadiqa Tul Hafsa

doi:10.46903/gjms/17.01.1981

FREQUENCY OF STAPHYLOCOCCUS AUREUS IN BLOOD STREAM INFECTIONS AND THEIR DRUG SUSCEPTIBILITY PATTERN

Nadia Aslam, Nazma Kiran, Naima Mehdi, Mateen Izhar, Tanveer Zia, Hadiqa Tul Hafsa

Abstract

Background: Staphylococcus aureus is important cause of blood stream infections. The objectives of this study were to determine the frequency of Staphylococcus aureus in blood stream infections and their antimicrobial drug susceptibility pattern.

Materials & Methods: This cross-sectional study was conducted at the Department of Pathology, Shaikh Zayed Hospital, Lahore from April 2018 to March 2019. The sample size was 1527 positive blood cultures for bacteria selected through consecutive sampling technique. Research variables were; presence of positive blood cultures, presence of staphylococci in positive blood cultures, types of staphylococci and types of staphylococcus aereus. Frequency and percentage of blood stream infection caused by Staphylococcus aureus and susceptibility of Staphylococcus aureus to various antimicrobial drugs was detected by disc diffusion and e-strip method.

Results: Out of 12744 blood cultures, 1527(11.98%) were positive for bacteria. Out of these 1527, 339(22.20%) were positive for staphylococci. Out of these 339, 87 (5.69%) were staphylococcus aureus. Out of these 87, 48 (3.14%) were methicillin resistant (MRSA). Susceptibility of S. aureus isolates to various commonly used drugs was also detected.

Conclusion: Staphylococcus aureus is a significant cause of blood stream infection and can exhibit multi-drug resistance. Therefore drug susceptibility profile of pathogens prevalent in hospital should be monitored and kept in mind when prescribing antimicrobial drugs before getting results of antimicrobial drug susceptibility tests.

Keywords

Staphylococcus aureus; Coagulase Negative Staphylococci; Blood Stream Infections; Bactaeremia.

Full Text:

PDF

References

Skogberg K, Lyytikainen O, Ollgren J, Nuorti JP, Ruutu P. Population based burden of bloodstream infections in Finland. Clin Microbiol Infect 2012; 18:170-6. https://doi.org/10.1111/j.1469-0691.2012.03845.x

Skogberg K, Lyytikainen O, Ruutu P, Ollgren J, Nuorti JP. Increase in bloodstream infections in Finland, 1995-2002. Epidemiol Infect 2008; 136:108-14. https://doi.org/10.1017/S0950268807008138

Von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002 Nov;2(11):677-85. https://doi.org/10.1016/S1473-3099(02)00438-3

Trueba F, Garrabe E, Hadef R, Fabre R, Cavallo JD, Tsvetkova K, et al. High prevalence of teicoplanin resistance among Staphylococcus epidermidis strains in a 5-year retrospective study. J Clin Microbiol 2006;44:1922-3. https://doi.org/10.1128/JCM.44.5.1922-1923.2006

Hassoun A, Linden PK, Friedman B. Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment. Crit Care 2017;21:211. https://doi.org/10.1186/s13054-017-1801-3

David MZ, Daum RS. Community-associated methicillin-resistant staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010; 23:616-87. https://doi.org/10.1128/CMR.00081-09

Naber CK. Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies, Clin Infect Dis. 2009 May 15;48 Suppl 4:S231-7. https://doi.org/10.1086/598189

Weinstein MP, Patel JB, Campeau S, Eliopoulos GM, Galas MF, Humphries RM, et al. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. M100, 28th ed. January 2018. Available at: http://iacld.ir/DL/public/CLSI-2018-M100-S28.pdf

Wilson J, Elgohari S, Livermore DM, Cookson B, Johnson A, Lamagni T, et al. Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect 2011; 17:451-8. https://doi.org/10.1111/j.1469-0691.2010.03262.x

Hall KK, Lyman JA. Updated review of blood culture contamination. Clin Microbiol Rev 2006; 19(4):788-802. https://doi.org/10.1128/CMR.00062-05

Aslam N, Mehdi N, Izhar M. Root cause analysis of methicillin resistant staphylococcus aureus bacteraemia. Pak Med Assoc 2015; 65(10):1089-93.

Centers for Disease Control and Prevention. Active bacterial core surveillance report, emerging infections program network, methicillin resistant Staphylococcus aureus, 2014. Available at: https://www.cdc.gov/abcs/reports-findings/survreports/mrsa14.pdf

Dellinger R, Levy M, Rhodes A, Annane D, Gerlach H, Opal S, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med 2013;39:165-228. Available at: http://insights.ovid.com/pubmed?pmid=23353941 https://doi.org/10.1007/s00134-012-2769-8

Gu B, Kelesidis T, Tsiodras S, Hindler J, Humphries RM. The emerging problem of linezolid-resistant Staphylococcus. J Antimicrob Chemother 2013; 68(1):4-11. Available at: https://academic.oup.com/jac/article/68/1/4/672000 https://doi.org/10.1093/jac/dks354

DOI: https://doi.org/10.46903/gjms/17.01.1981